Spotlight -

Drug Development|

Quality Systems

Guido M. Furer

Articles by Guido M. Furer

Import Testing of Pharmaceutical Products Has Limited Safety Benefits and Can Add Risk to Patients

ByStephan Rönninger,Karl Ennis,Joerg H.O. Garbe,Guido M. Furer,Maria G. Jacobs

August 2nd 2015

Latest Updated Articles

Import Testing of Pharmaceutical Products Has Limited Safety Benefits and Can Add Risk to Patients
August 2nd 2015

Trending on Pharmaceutical Technology

FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations

Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026

1074 Revision Needs Formulator Feedback: AAPS PharmSci 360 2026

AAPS PharmSci 360 2026: Spray Drying and ASD

RRP Accelerated Approval: What VOCERYQ Means for Manufacturing Teams